CHARACTERIZATION OF THE INTERLEUKIN-2 RECEPTORS (IL-2R) EXPRESSED ON HUMAN NATURAL-KILLER-CELLS ACTIVATED INVIVO BY IL-2 - ASSOCIATION OF THE P64 IL-2R GAMMA-CHAIN WITH THE IL-2R BETA-CHAIN IN FUNCTIONAL INTERMEDIATE-AFFINITY IL-2R

被引:147
作者
VOSS, SD
SONDEL, PM
ROBB, RJ
机构
[1] UNIV WISCONSIN,CTR CLIN SCI,DEPT PEDIAT,MADISON,WI 53792
[2] UNIV WISCONSIN,CTR CLIN SCI,DEPT GENET,MADISON,WI 53792
[3] DUPONT MERK PHARMACEUT CO,WILMINGTON,DE 19880
关键词
D O I
10.1084/jem.176.2.531
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Interleukin 2 (IL-2) receptors expressed on the surface of activated T cells and natural killer (NK) cells exhibit a variety of affinity states depending on their subunit composition. Low-affinity binding is associated with a 55-kD alpha-chain, intermediate-affinity binding with a 70-75-kD beta-chain, and high-affinity binding with a bimolecular complex of the alpha and beta-subunits. In a previous study of the IL-2 receptors expressed on NK cells obtained from cancer patients after in vivo IL-2 therapy, we documented a discrepancy between the level of beta-chain and the level of intermediate-affinity IL-2 binding sites expressed on the cell surface. Based on this result, we postulated that formation of intermediate-affinity receptor sites required a component in addition to the beta-chain, and that this component was present at limiting levels in the patient NK cells. In the present study we have examined the structure of the intermediate-affinity receptor complex using monoclonal antibodies that recognize the beta-chain, but that do not interfere with its ability to bind IL-2. Evidence is presented establishing the physical association of a novel protein of 64 kD with the beta-chain in intermediate-affinity IL-2 binding sites. This molecule, termed IL-2R gamma-chain, coprecipitated with beta-chains prepared from cells that had been incubated with IL-2, but was undetectable in immunoprecipitates prepared in the absence of IL-2. Examination of gamma-chain expression in post-IL-2 therapy NK cells, where only low levels of intermediate-affinity IL-2 binding were detectable, revealed that the gamma-chain was associated with, on average, only 10-12% of the beta-chains expressed on such cells. This contrasted with approximately equal levels of beta and gamma-chain expression on YT cells, a cell line that has both high levels of cell surface beta-chain expression and high levels of IL-2 binding. Thus, the ratio of gamma-chain to beta-chain present in the immunoprecipitates roughly correlated with the proportion of beta-chain involved in intermediate-affinity receptor sites. This result suggests that the 64-kD gamma-chain is the component responsible for regulating the affinity of IL-2 association with the beta-subunit. By further defining the structural components necessary for IL-2 receptor formation, these studies provide additional insight into mechanisms whereby lymphocytes might regulate their responsiveness to IL-2.
引用
收藏
页码:531 / 541
页数:11
相关论文
共 55 条
[1]   FC-GAMMA RECEPTOR TYPE-III (CD16) IS INCLUDED IN THE ZETA-NK RECEPTOR COMPLEX EXPRESSED BY HUMAN NATURAL-KILLER-CELLS [J].
ANDERSON, P ;
CALIGIURI, M ;
OBRIEN, C ;
MANLEY, T ;
RITZ, J ;
SCHLOSSMAN, SF .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (06) :2274-2278
[2]   THE EVIDENCE FOR THE IL-2 RECEPTOR-BETA CHAIN PROCESSING FROM P70 TO P75 [J].
ASAO, H ;
TAKESHITA, T ;
NAKAMURA, M ;
NAGATA, K ;
SUGAMURA, K .
INTERNATIONAL IMMUNOLOGY, 1990, 2 (05) :469-472
[3]   INTERLEUKIN-2 (IL-2)-INDUCED TYROSINE PHOSPHORYLATION OF IL-2 RECEPTOR-P75 [J].
ASAO, H ;
TAKESHITA, T ;
NAKAMURA, M ;
NAGATA, K ;
SUGAMURA, K .
JOURNAL OF EXPERIMENTAL MEDICINE, 1990, 171 (03) :637-644
[4]   SERUM CD25 LEVELS DURING INTERLEUKIN-2 THERAPY - DOSE DEPENDENCE AND CORRELATIONS WITH CLINICAL TOXICITY AND LYMPHOCYTE SURFACE SCD25 EXPRESSION [J].
BOGNER, MP ;
VOSS, SD ;
BECHHOFER, R ;
HANK, JA ;
ROPER, M ;
POPLACK, D ;
HAMMOND, D ;
SONDEL, PM .
JOURNAL OF IMMUNOTHERAPY, 1992, 11 (02) :111-118
[5]  
COLAMONICI OR, 1990, J IMMUNOL, V145, P155
[6]   A NEW CYTOKINE RECEPTOR SUPERFAMILY [J].
COSMAN, D ;
LYMAN, SD ;
IDZERDA, RL ;
BECKMANN, MP ;
PARK, LS ;
GOODWIN, RG ;
MARCH, CJ .
TRENDS IN BIOCHEMICAL SCIENCES, 1990, 15 (07) :265-270
[7]   A 2ND HUMAN INTERLEUKIN-2 BINDING-PROTEIN THAT MAY BE A COMPONENT OF HIGH-AFFINITY INTERLEUKIN-2 RECEPTORS [J].
DUKOVICH, M ;
WANO, Y ;
THUY, LTB ;
KATZ, P ;
CULLENS, BR ;
KEHRL, JH ;
GREENE, WC .
NATURE, 1987, 327 (6122) :518-522
[8]  
FARRAR WL, 1989, J BIOL CHEM, V264, P12562
[9]   CO-INTERNALIZATION OF THE P55 AND P70 SUBUNITS OF THE HIGH-AFFINITY HUMAN INTERLEUKIN-2 RECEPTOR - EVIDENCE FOR A STABLE TERNARY RECEPTOR COMPLEX [J].
FUNG, MR ;
JU, G ;
GREENE, WC .
JOURNAL OF EXPERIMENTAL MEDICINE, 1988, 168 (05) :1923-1928
[10]  
FUNG MR, 1991, J IMMUNOL, V147, P1253